Xenetic Biosciences (XBIO) is scheduled to report Q2 earnings on August 12, 2026.
Xenetic Biosciences has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Xenetic Biosciences has averaged an EPS surprise of 0.35% and a revenue surprise of 0.41%.
Analyze the earnings history of Xenetic Biosciences using advanced sorting and filters.
The chart below shows Xenetic Biosciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Xenetic Biosciences's reported revenue compared to analyst estimates over recent quarters.
Xenetic Biosciences (XBIO) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
The Actual EPS was $-0.20, which missed the estimate of $0.00.
The Actual Revenue was $806.92K, which beat the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-13 | $-0.22 | $-0.52 | 57.7 % |
| Q3 | 2025-11-13 | $-0.33 | $-0.51 | 35.3 % |
| Q2 | 2025-08-13 | $-0.45 | $-0.65 | 29.7 % |
| Q1 | 2025-05-13 | $-0.59 | $-0.72 | 18.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-13 | $766.30K | $525.00K | 46.0 % |
| Q3 | 2025-11-13 | $1.03M | $525.00K | 95.6 % |
| Q2 | 2025-08-13 | $589.90K | $545.20K | 8.20 % |
| Q1 | 2025-05-13 | $593.26K | $516.00K | 15.0 % |